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Scope: Shellfish allergy is an increasing global health priority, frequently
affecting adults. Molluscs are an important shellfish group causing food
allergy but knowledge of their allergens and cross-reactivity is limited.
Optimal diagnosis of mollusc allergy enabling accurate advice on food
avoidance is difficult. Allergens of four frequently ingested Asia-Pacific
molluscs are characterized: Sydney rock oyster (Saccostrea glomerata), blue
mussel (Mytilus edulis), saucer scallop (Amusium balloti), and southern
calamari (Sepioteuthis australis), examining cross-reactivity between species
and with blue swimmer crab tropomyosin, Por p 1.
Methods and results: IgE ELISA showed that cooking increased IgE reactivity
of mollusc extracts and basophil activation confirmed biologically relevant IgE
reactivity. Immunoblotting demonstrated strong IgE reactivity of several
proteins including one corresponding to heat-stable tropomyosin in all
species (37–40 kDa). IgE-reactive Sydney rock oyster proteins were identified
by mass spectrometry, and the novel major oyster tropomyosin allergen was
cloned, sequenced, and designated Sac g 1 by the IUIS. Oyster extracts
showed highest IgE cross-reactivity with other molluscs, while mussel
cross-reactivity was weakest. Inhibition immunoblotting demonstrated high
cross-reactivity between tropomyosins of mollusc and crustacean species.
Conclusion: These findings inform novel approaches for reliable diagnosis
and improved management of mollusc allergy.
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1. Introduction
Shellfish allergy is an increasingly
important global health priority, often
presenting in childhood and typically
persisting into adulthood.[1–3] Reac-
tions range from mild irritation to
life-threatening anaphylaxis,[4] currently
with only emergency treatment and no
allergen-specific therapy available.[5,6]
Molluscs are a major group of shellfish
causing food allergy, but in many studies
they are combined with crustaceans un-
der the term shellfish.[7] Consequently,
mollusc allergy is clinically under-
reported and allergens are ill-defined.
To date only four mollusc allergens
are listed in the WHO/International
Union of Immunological Societies
(IUIS) Allergen Nomenclature Sub-
Committee database, all of which are
different tropomyosins (http://www.
allergen.org/index.php). Additional mol-
lusc allergens have been reported, but
not yet fully characterized.[8,9] Elucidation
of the full range and immunoreactiv-
ity of mollusc allergens will facilitate
more precise diagnostic tools and much
needed specific immunotherapy.
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As for other shellfish groups, tropomyosin has been identified
as a major allergen for several mollusc species.[10–15] It is a highly
water-soluble and heat-stable protein, found in both muscle and
non-muscle cells. Other allergens identified in mollusc species
include paramyosin, hemocyanin, myosin heavy chain, amy-
lase, arginine kinase, and triosephosphate isomerase.[8,9] How-
ever, the clinical importance and cross-reactivity of these aller-
gens are unclear. Patients frequently show clinical reactivity to
both mollusc and crustacean shellfish species. It has not been
established whether this is true IgE cross-reactivity or simply co-
sensitization to mollusc and crustacean allergens. While crus-
tacean tropomyosins show very high amino acid sequence iden-
tity (up to 98%) with IgE cross-reactivity as demonstrated by us
and others,[16,17] the reported sequence identity between crus-
tacean and mollusc tropomyosins is only 56–68%.[13] Whether
there is sufficient homology at IgE binding epitopes for clinically
relevant cross-reactivity is unknown.
Food processing, including heating and digestion, can
affect IgE reactivity of allergens by chemically altering pro-
tein structures via different processes including aggregation,
polymerization, and degradation.[18–20] Heating can also alter
conformation of proteins and hence allergenicity by disrupting
disulfide bonds. Tropomyosin has no disulfide bonds, consistent
with its relative heat stability,[21,22] but the impact of heating on
other mollusc allergens is ill-defined. Nakamura and colleagues
showed that particular sugars influenced the effect of the Mail-
lard reaction during heating on the allergenicity of tropomyosin
from two mollusc species with conflicting results: allergenicity
of squid tropomyosin was decreased and scallop tropomyosin
increased.[23,24]
We report here the characterization of allergens in four com-
monly consumed Asia-Pacific mollusc species: Saccostrea glomer-
ata (Sydney rock oyster, SRO),Mytilus edulis (blue mussel), Amu-
sium balloti (saucer scallop), and Sepioteuthis australis (southern
calamari). SRO allergens were identified by mass spectrometry,
the novel oyster tropomyosin Sac g 1 was sequenced, and cross-
reactivity with other mollusc and crustacean tropomyosins as-
sessed. The effect of heat treatment of mollusc extracts on IgE
reactivity was also examined. The findings of this study will in-
form novel and reliable diagnostic approaches to enhance man-
agement of mollusc allergy.
2. Experimental Section
2.1. Study Population, Sera, and Ethics Statement
Sera were obtained from 13 patients recruited from the Alfred
Hospital Allergy Clinic with a clinical history of seafood al-
lergy and positive mollusc-specific IgE by ImmunoCAP (>0.35
kUA L–1; Phadia Pty Ltd, Uppsala, Sweden; Table 1; mean age
33.8 ± 9.2 years; 10 F/3 M). Two nonatopic control subjects
were recruited with negative skin prick tests to a panel of com-
mon aeroallergens and no clinical history of seafood allergy.
A non-shellfish allergic, atopic control subject with negative
seafood- and house dust mite–specific IgE, and positive ryegrass
pollen–specific IgE was included. The study was approved by
the Alfred Hospital Research Ethics Committee (Project number
192/07) and the Monash University Human Ethics Committee
(MUHREC CF08/0225) and informed written consent was ob-
tained from each subject.
2.2. Mollusc Extract Preparation
Flesh from fresh Sydney rock oyster (S. glomerata) with (raw oys-
ter, RO) or without visceral mass (ROvm), bluemussel (M. edulis;
RM), saucer scallop (A. balloti; RS), and southern calamari (S. aus-
tralis; RC) was removed from its shell, sliced into fine pieces and
incubated in PBS pH 7.2 overnight at 4 °C with constant mixing.
After centrifugation at 13 000 × g at 4 °C for 20 min, the super-
natant was collected, filter-sterilized, and stored at −80 °C. For
cooked SRO with (CO) or without visceral mass (COvm), blue
mussel (CM), saucer scallop (CS), and southern calamari (CC)
extracts, the whole molluscs were cooked in boiling PBS for 20
min prior to extract preparation as above. Extract protein concen-
trations were determined using the Bradford assay kit (Bio-Rad
Laboratories, Hercules, CA).
2.3. IgE ELISA and Inhibition ELISA
IgE ELISA was performed as described previously.[16] Briefly,
1 μg mL−1 extract was coated onto 96-well EIA/RIA plates
(Costar, St. Louis, MO) and screened with patient sera diluted
1:10 in 1% skim milk powder/0.05% Tween/PBS. IgE binding
was detected using rabbit anti-human IgE (1:4000 dilution; Dako,
Glostrup, Denmark) and goat anti-rabbit IgG-HRP (1:1000 dilu-
tion; Promega, Madison, WI).
Inhibition IgE ELISA was performed as described[16] using
sera previously found positive (O.D.450 nm  1.5 at 1:10 dilution)
by direct ELISA for the relevant coating extract: for CC—A8, A10,
A13; CM—A8, A11; CS—A8, A10, A13; CO—A7, A8, A10, A11,
A13, and COvm—A2, A8, A10, A13. Sera were first titrated for
IgE reactivity with the mollusc extract to determine the serum
concentration at which the O.D.450 nm was 1 and within the
linear phase of the titration curve. Using this dilution, patient
sera were preincubated with increasing concentrations of mol-
lusc extracts or ovalbumin (OVA, negative control) for 1 h at room
temperature before testing by ELISA as above. The percentage
inhibition was calculated as 100 − [(O.D.450 nm of serum with
inhibitor/O.D.450 nm of serum without inhibitor) × 100]. To al-
low comparison between patients, the concentration required for
50% inhibition of IgE binding was determined. To assess non-
specific inhibition bymollusc extracts, serum from a non-seafood
allergic, atopic (ryegrass pollen-sensitized) subject was incubated
with the above inhibitors, and then tested for IgE reactivity with
ryegrass pollen extract in comparison with untreated serum.
2.4. Basophil Activation Test
In vitro basophil activation by the mollusc extracts was assessed
as described previously.[25] Briefly, heparinized blood was incu-
bated with the extracts (0.05–5 μg mL–1) for 20 min at 37 °C.
Basophil activation was assessed by flow cytometry by determin-
ing the percentage of viable, high IgE-expressing, CD63+ cells
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Table 1. Clinical characteristics of mollusc-sensitized, seafood-allergic subjects.
No. Sex Age Total IgE [IU mL–1] Specific IgE [kUA L–1] Clinical presentation
Oyster Mussel Scallop Calamari Symptoms with Symptoms
A1 F 20 242 0.42 0.10 0.18 0.55 Prawn As, R, U
A2 F 34 199 0.93 0.57 1.93 4.19 Prawn, crab, calamari, lobster R, U, A, An
A3 F 31 2231 0.09 0.05 0.53 0.22 Prawn, crab, fish As, R, An, U
A4 F 26 1946 0.92 0.61 1.13 1.07 Flounder, prawn, crab R, A, An
A5 M 45 976 2.04 9.27 5.10 10.2 Calamari, snapper, tuna R, An
A6 F 33 28 3.75 2.84 3.00 5.21 Shellfish, scallops, oyster U, An, pO
A7 M 44 140 4.29 0.07 0.17 0.02 Flake, sea perch, rockling pO, An
A8 M 33 183 1.04 0.98 0.46 1.36 Mussel, scallops An
A9 F 45 167 5.99 NT NT NT Shellfish As, R, U, An
A10 F 32 130 2.41 NT NT NT Crab An
A11 F 48 579 1.11 1.09 1.99 2.63 Crustaceans/molluscs R, H, A
A12 F 24 266 6.68 NT NT NT Salmon, crab, lobster, shrimp An
A13 F 24 227 2.59 0.63 4.66 1.95 Prawns, calamari, fish An
NT, not tested; As, asthma; R, rhinitis; U, urticaria; A, anaphylaxis; An, angioedema; pO, periorbital edema; H, hypotension.
(gating strategy shown in ref. 25). Rabbit anti-human IgE (Dako)
and f-Met-Leu-Phe (fMLP; Sigma, St. Louis, MO) were used as
positive controls and OVA (0.05–5 μg mL−1) and stimulation
buffer alone as negative controls.
2.5. SDS-PAGE, IgE Immunoblot, and IgE Inhibition Immunoblot
Mollusc extract proteins were separated by SDS-PAGE and
stained with Coomassie Brilliant Blue as described previously.[16]
For IgE immunoblotting, mollusc proteins were resolved on a
4–12% Bis–Tris gel (2D-well, NuPage, Carlsbad, CA) at a con-
centration of 1 μg protein per millimeter of gel well width and
transferred to 0.45 μmnitrocellulose membrane (Thermo Scien-
tific, Rockford, IL). IgE reactivity of separated proteins was de-
termined by sequential probing with patient serum (300 μL per
mini-blotter well, 1:40 dilution), rabbit anti-human IgE (20 mL
per immunoblot, 1:15 000 dilution; Dako) and goat anti-rabbit
IgG-HRP (20 mL per immunoblot, 1:15 000; Promega) as de-
scribed previously.[16]
For IgE inhibition immunoblotting, sera (1:30 final dilution)
were preincubated for 1 h at room temperature with rPor p 1
(0.4 μg mL–1, 2 μg mL–1, and 10 μg mL–1), OVA (20 μg mL–1,
negative control), or the same mollusc extract (20 μg mL–1) as
used for the binding assay (positive control). The preincubated
sera were then tested for IgE reactivity with the mollusc extracts
by immunoblotting as above. Nonspecific inhibition by mollusc
extracts was assessed as described for the inhibition IgE ELISA
above.
2.6. Identification of IgE-Reactive Sydney Rock Oyster Proteins by
Mass Spectrometry
Bands corresponding to highly IgE-reactive proteins of raw and
cooked SRO extracts with visceral mass were excised from SDS-
PAGE gels for mass spectrometric analysis (Monash Biomedi-
cal Proteomics Facility, MonashUniversity, Australia). Briefly, the
protein bands were destained, reduced, and alkylated. The gel
pieces were washed and dehydrated, followed by trypsin diges-
tion. The gel pieces were then sonicated and analyzed by LC-
MS/MS on a HCT ULTRA ion trap mass spectrometer (Bruker
Daltonics, Bremen, Germany) coupled online with an Ultimate
3000 nano HPLC (Dionex Corp., Sunnybrook, CA, USA). Data
were exported in Mascot generic file format and searched against
the Swiss-Prot databases using the MASCOT search engine (ver-
sion 2.1, Matrix Science Inc., London, UK) with all taxonomy
selected.
2.7. Sequence Analysis of Sydney Rock Oyster Tropomyosin
To determine the amino acid sequence of SRO tropomyosin,
cDNA was amplified and sequenced as we described for blue
swimmer crab.[16] Briefly, total RNA was extracted from SRO
muscle using TRizol reagent (Life Technologies, Carlsbad, CA,
USA) and single-stranded cDNA was reverse transcribed from
the RNA using RT-PCR (cDNA synthesis kit; Bioline, Sydney,
Australia). The tropomyosin coding region was amplified using
forward (5ʹ CGC AGA ATT CAT GAC AGC ATC AAG AAG AAG
ATG 3ʹ) and reverse (5ʹ CGA ACC TGC AGT TAA TAT CCT
GCC AGC TCG G 3ʹ) primers. The primers were designed based
on the nucleotide sequence for the closely related Pacific oyster
(Crassostrea gigas) tropomyosin (GenBank accession number
AB444943.1). PCR products were cloned into a sequencing vec-
tor, pCR 2.1, using the TOPO TA cloning kit (Life Technologies,
Carlsbad, CA, USA) and transformed into TOP10 chemical com-
petent Escherichia coli. Positive colonies were confirmed by blue–
white screening and colony PCR using gene-specific oligonu-
cleotide primers for the presence of inserts. Plasmids were puri-
fied from overnight culture using an AxyPrep Plasmid Miniprep
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Figure 1. SDS-PAGE analysis of raw and cooked mollusc extracts.
Coomassie Brilliant Blue stained 4–12% reducing SDS-PAGE gel of raw
and cooked mollusc extracts. RC, raw calamari; CC, cooked calamari; RM,
raw mussel; CM, cooked mussel; RS, raw scallop; CS, cooked scallop; RO,
raw oyster; CO, cooked oyster; ROvm, raw oyster without visceral mass;
COvm, cooked oyster without visceral mass.
Kit (Axygen Biosciences, Union City, CA, USA) and sequenced
(Macrogen DNA sequencing services, Melbourne, Australia).
2.8. Statistical Analysis
The Friedman test in conjunction with Dunn’s multiple compar-
ison test was used to compare serum IgE reactivity between mol-
lusc extracts. Differences were defined as statistically significant
at p < 0.05. The Spearman’s rank correlation test was used to
assess correlation between IgE ELISA and ImmunoCAP values.
Analyses were performed using GraphPad Prism for Windows
(GraphPad, San Diego, CA).
3. Results
3.1. SDS-PAGE Analysis of Raw and Cooked Mollusc Extracts
Analysis of mollusc extracts by SDS-PAGE revealed a range of
proteins from 5 to >188 kDa (Figure 1). Protein profiles differed
greatly between species, but a prominent protein band was ob-
served at 39–40 kDa for all the cooked extracts, seen at a slightly
lowermolecularmass (37–39 kDa) andmore faintly in the raw ex-
tracts, consistent with known tropomyosins (35–39 kDa). There
was a pronounced difference between the raw and cooked extract
protein profiles with very few protein bands running at the same
position in both extracts. Raw extracts from all species contained
several higher molecular mass proteins (>140 kDa). These were
not detectable after cooking. Conversely, several protein bands ap-
peared in the cooked extracts that were not observed in the raw ex-
tracts consistent with heat denaturation of proteins to fragments
and production of multimers.
A comparison of oyster extracts prepared with and without the
visceral mass revealed a clearer protein profile for the extracts
lacking the visceral mass (ROvm and COvm), particularly for
Figure 2. Patient serum IgE reactivity by ELISA. Comparison of serum
IgE from allergic patients (n = 13) binding to mollusc extracts show-
ing the median and distribution of O.D. 450 nm. *Comparison be-
tween raw and cooked extracts, +comparison to raw mussel extract,
§comparison to raw calamari extract, and #comparison to raw oyster ex-
tract. ***/+++/§§§/### p < 0.001; **/++/§§/## p < 0.01 and */+/§/#
p < 0.05. RC, raw calamari; CC, cooked calamari; RM, raw mussel; CM,
cooked mussel; RS, raw scallop; CS, cooked scallop; RO, raw oyster; CO,
cooked oyster; ROvm, raw oyster without visceral mass; COvm, cooked
oyster without visceral mass.
the raw extract likely due to removal of endogenous proteinases.
However, there was no overall difference in protein profile except
for the more prominent band at 20 kDa seen only in the ROvm
extract (Figure 1).
3.2. IgE ELISA
IgE ELISA showed that all cooked mollusc extracts had higher
overall IgE reactivity than their corresponding raw extract, al-
though this difference was not statistically significant for scal-
lop or oyster without visceral mass (Figure 2). For individual pa-
tients, a positive reaction to raw extract generally corresponded
with a positive reaction to the corresponding cooked extract and
vice versa. The rawmussel and oyster extracts had lower IgE reac-
tivity than the raw scallop and calamari extracts, but there was no
significant difference in IgE reactivity between any of the cooked
extracts. Removal of the oyster visceral mass increased IgE bind-
ing of the raw extract, but this difference was not seen for the
cooked extracts which both showed strong IgE reactivity.
Comparison between patient oyster ImmunoCAP and IgE
ELISA values revealed a positive correlation for both raw (r2 =
0.7, p = 0.005) and cooked (r2 = 0.77, p = 0.0012) oyster ex-
tracts. Removal of the visceral mass did not impact this correla-
tion. There was a strong correlation between mussel Immuno-
CAP and cooked blue mussel (CM) IgE ELISA values (r2 = 0.82,
p = 0.002), but interestingly, no correlation for the raw mussel
extract. IgE ELISA reactivity for raw or cooked scallop and cala-
mari extracts showed no correlation with respective Immuno-
CAP values.
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3.3. Basophil Activation Test
The biological relevance of mollusc allergen-specific IgE was as-
sessed by stimulation of basophils in peripheral whole blood
from two of the patients (A8 and A10) with the mollusc ex-
tracts and flow cytometry (Figure 3). Activated basophils were
identified by high IgE expression and upregulation of CD63 on
the cell surface.[23] No nonspecific activation or toxicity by the
mollusc extracts was observed on testing basophils from a non-
mollusc allergic, atopic subject (Figure 3C). However, there was
strong, dose-dependent activation of basophils from themollusc-
sensitized subjects, with higher activation for subject A10 com-
pared with A8 and reaching a plateau for some extracts (Fig-
ure 3A,B). Again, the cooked extracts induced greater basophil
activation than the corresponding raw extracts and removal of
the visceral mass from the raw oyster extract increased basophil
activation.
3.4. IgE Immunoblot
IgE-reactive proteins within each of the mollusc extracts were
examined by immunoblotting (Figure 4). The results are sum-
marized in allergograms in Figure 5. Overall, there was stronger
intensity of IgE binding and a larger number of IgE-reactive
proteins in the cooked extracts compared to the raw extracts,
except for calamari where the raw extract was more IgE reactive.
The most frequently recognized band was at 37–40 kDa, that is,
in the tropomyosin region. Reactivity to this band was >60% for
all mollusc species either for the raw, cooked, or both extracts.
For scallop, mussel, and oyster extracts, cooking increased the
percentage of subjects showing IgE reactivity to this region, with
oyster extracts showing the greatest reactivity (CO 69%, COvm
77%). All subjects who showed IgE reactivity to a band in the
tropomyosin region in the raw extracts showed IgE reactivity to
a slightly lower sized band in the cooked extracts. In the case
of calamari, the raw extract showed greater IgE reactivity at this
region than the cooked extract (69% vs. 39%). There were several
other IgE-reactive bands recognized at high frequency, especially
in the oyster extracts (Figure 5). Proteins from these bands were
identified by mass spectrometry as described below.
For the cooked calamari and mussel extracts, the bands seen
at 31 kDa and 55 kDa, respectively, for all subjects were shown in
control experiments to be due to nonspecific binding of the sec-
ondary antibody to the proteins in the absence of patient serum
(data not shown).
3.5. Inhibition IgE ELISA
Inhibition IgE ELISA was used to assess IgE cross-reactivity
between whole mollusc extracts and the effect of cooking on
cross-reactivity (Figure 6). Sera were preincubated with cooked or
raw extracts and tested for IgE reactivity with cooked extracts. As
expected, inhibition of IgE binding was generally highest when
inhibitor and coating extract species were the same. Cooked
mollusc extracts consistently showed higher inhibition of IgE re-
activity with cooked extracts from other species than raw extracts.
Figure 3. Assessment of functional IgE reactivity to mollusc extracts by
basophil activation. Whole blood from patients A) A8, B) A10, and C) a
non-mollusc but ryegrass pollen-allergic control were stimulated in vitro
withmollusc extracts at 0.05μgmL–1 (open bars), 0.5μgmL–1 (grey bars),
and 5 μg mL–1 (black bars) or controls (striped bars; OVA and SB as neg-
ative controls, anti-IgE and fMLP as positive controls). Basophil activation
was assessed by the percentage of live cells expressing high levels of IgE
and CD63. RC, raw calamari; CC, cooked calamari; RM, raw mussel; CM,
cooked mussel; RS, raw scallop; CS, cooked scallop; RO, raw oyster; CO,
cooked oyster; ROvm, raw oyster without visceral mass; COvm, cooked
oyster without visceral mass; SB, stimulation buffer.
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Figure 4. Immunoblot analysis of patient IgE reactivity to mollusc extracts. IgE reactivity to A–E) raw and F–J) cooked mollusc extracts was tested using
sera from allergic (1–13) and nonatopic (NA1–2) subjects. A,F) Calamari. B,G) Mussel. C,H) Scallop. D,I) Oyster. E,J) Oyster without visceral mass.
Scallop and oyster were strong inhibitors of IgE binding to cala-
mari, and conversely calamari and oyster inhibited IgE binding
to scallop strongly. Overall, oyster inhibitors showed the highest
cross-reactivity with other mollusc extracts, with the highest level
of inhibition shown to mussel. Confirming specificity of the in-
hibition ELISA, no inhibition of IgE binding to mollusc extracts
was observed in the presence of the negative control inhibitor
(OVA; Figure 6) and the mollusc extracts showed negligible non-
specific inhibition of the control non-shellfish allergic subject
serum IgE binding to ryegrass pollen extract (data not shown).
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Figure 5. Allergogram analysis of IgE reactivity by immunoblot to mol-
lusc proteins. Percentage of patients with reactivity to IgE-bindingmollusc
proteins is shown (n = 13). Intensity of IgE reactivity is graded as weak
(white), moderate (gray), or strong (black).
3.6. Inhibition IgE Immunoblot
Inhibition IgE immunoblotting was used to examine the ef-
fect of cooking on mollusc tropomyosin cross-reactivity with the
well-characterized blue swimmer crab tropomyosin, rPor p 1[16]
(Figure 7). Confirming specificity of the inhibition immunoblot
assay, for each subject tested there was no inhibition of IgE bind-
ing to mollusc extracts by OVA (nonspecific allergen) when com-
pared to the “no inhibitor” control, while whole cooked mollusc
extracts were able to completely inhibit IgE reactivity to their re-
spective extracts. Themollusc extracts showed negligible nonspe-
cific inhibition of the control non-shellfish allergic subject serum
IgE binding to ryegrass pollen extract (data not shown).
Two relevant subjects for each cooked mollusc extract, that is,
with IgE reactivity to a band in the tropomyosin region, were se-
lected. The crustacean tropomyosin rPor p 1 inhibited IgE reac-
tivity to the “tropomyosin” band for all four mollusc species. In
most cases, the inhibition was dose dependent, but for one sub-
ject’s serum IgE reactivity tomussel extract (Figure 7C) there was
complete inhibition at all rPor p 1 concentrations tested. For one
serum tested against CC (Figure 7A), there was no reduction in
IgE binding to the band at around 30 kDa suggesting that this
was not tropomyosin. IgE-reactive proteins at 30, 48, 67, and 81
kDa in CO, 49 and 81 kDa in CM, and 76 kDa in CS were also
inhibited by Por p 1, consistent with cross-reactive tropomyosin
fragments and multimers in the extracts. These findings indi-
cate substantial cross-reactivity between tropomyosin proteins of
mollusc and crustacean shellfish species.
3.7. Identification of IgE-Reactive Sydney Rock Oyster Proteins
To further characterize SRO allergens, we excised IgE-reactive
bands for mass spectrometric identification (Table 2). Bands at
34, 39, 45, and 72 kDa were identified as tropomyosin in the
cooked oyster extract, consistent with heat-induced degradation
and aggregation. In addition, four proteins were identified from
other IgE-reactive SRO bands: glyceraldehyde-3-phosphate dehy-
drogenase at 38 kDa, fructose-bisphosphate aldolase and argi-
nine kinase at 45 kDa in the raw but not cooked SRO preparation,
and a fragment of myosin heavy chain in the cooked preparation
at 89 kDa.
3.8. Sequencing and Characterization of Sydney Rock Oyster
Tropomyosin
The RNA of the highly IgE-reactive 38–39 kDa protein from
the oyster extracts (as assessed by immunoblot and identified as
tropomyosin as above) was cloned and reverse transcribed into
cDNA to obtain the complete sequence (Figure 8). This allergen
has been designated Sac g 1 by the IUIS allergen nomenclature
subcommittee (http://www.allergen.org/index.php) based on
subsequent further testing of IgE reactivity of the purified protein
(data not shown). Alignment of known tropomyosin sequences
for different shellfish species shows that SRO tropomyosin has
very high sequence identity with tropomyosin from another oys-
ter species (Pacific oyster), and lower identity with two bivalves
(blue mussel and bay scallop) and the cephalopod Japanese fly-
ing squid (Figure 8). The crustacean tropomyosin Por p 1 had
only 60% sequence identity with SRO tropomyosin.
4. Discussion
Diagnosis of mollusc allergy is often difficult due to unreliable
clinical history as patients may be unaware of the specific trig-
ger of their food-allergic reaction. Currently, food challenge is
the most reliable way to identify food allergy. However, this
Mol. Nutr. Food Res. 2018, 62, 1800148 1800148 (7 of 12) C© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.advancedsciencenews.com www.mnf-journal.com
Figure 6. Inhibition IgE ELISA. Inhibition of IgE reactivity to cooked extracts by each mollusc extract is represented by the frequency of patients showing
inhibition and the concentration of mollusc inhibitor required to achieve 50% inhibition of IgE reactivity: 0.16–0.8 μg mL–1 (black), 0.9–4 μg mL–1 (dark
gray), 5–20μg mL–1 (light gray), 21–100μg mL–1 (spotted), or>100μg mL–1 (white). Patient sera used for each assay were those showing IgE reactivity
to the coating extract by direct ELISA.
procedure may be associated with risk of serious adverse reac-
tions in the case of shellfish challenge due to high allergen po-
tency and adult patient comorbidities. For practical reasons, this
diagnostic procedure is seldom conducted in adults. A reliable
laboratory-based assay is needed. Hence, we sought to character-
ize allergens in four commonly consumed Asia-Pacific mollusc
species, assessing frequency of recognition by patient IgE and
cross-reactivity. The effect of heating on IgE reactivity of mollusc
extracts was also examined. SRO (S. glomerata) tropomyosin, Sac
g 1, was sequenced and cross-reactivity with other mollusc and
crustacean tropomyosins assessed.
In order to confirm clinical relevance of IgE reactivity identi-
fied by direct IgE binding assays, an effector cell-based in vitro
basophil activation test (BAT) was used. In this assay, native al-
lergen extract was used, presenting conformational as well as lin-
ear IgE epitopes. Basophil activation following in vitro allergen
challenge as assessed by CD63 expression is a well-recognized
correlate of histamine release and clinical reactivity (e.g., ref.26).
BAT responses for the two patients tested trended with direct IgE
ELISA values and aligned closely with given clinical histories.
This test has promising potential for assessing immediate type
food allergy in clinical practice.[27]
The correlation of IgE reactivity by ELISA and ImmunoCAP
differed between mollusc species. Oyster- and mussel-specific
IgE levels by ELISA showed significant correlation with Im-
munoCAP values, not seen for scallop and calamari. As both
specificity and sensitivity of assays are important for accurate
clinical diagnosis, the potency and relevance of allergens used
in assay preparations are pivotal. Except for blue mussel, current
ImmunoCAP preparations do not include Asia-Pacific species,
likely explaining the limited correlation between our IgE ELISA
using locally consumed mollusc species and ImmunoCAP val-
ues. Critical to selection of mollusc species for diagnostic assays
is knowledge of IgE cross-reactivity between different mollusc
species and between mollusc and crustacean species, as well as
the effects of heating on IgE reactivity as we report here. IgE im-
munoblotting revealed a high frequency of patient IgE reactivity
to a heat-stable 37–40 kDa protein in each of the four mollusc
species, consistent with tropomyosin being a major allergen as
for other mollusc species.[28–30] We confirmed that this protein
was tropomyosin for the highly IgE-reactive SRO by mass spec-
trometry and report here, for the first time, the cloning and full
sequence analysis of S. glomerata tropomyosin, Sac g 1. This re-
vealed strong amino acid sequence identity with another known
oyster tropomyosin, but lower identity with tropomyosin from
two bivalves and a cephalopod, and even less with the crustacean
tropomyosin Por p 1. The level of identity was reflected in the in-
hibition IgE immunoblotting experiments, where Por p 1 could
reduce IgE binding to Sac g 1, but to a lower extent than other
mollusc tropomyosins.
In this study, not all subjects showed IgE reactivity to the
putative tropomyosin of the four mollusc species. Therefore,
tropomyosin-specific IgE testing alone is insufficient for diagno-
sis ofmollusc allergy.We also observed IgE reactivity to other pro-
teins with molecular masses corresponding to those of known
mollusc allergens. These included paramyosin (100 kDa),[31]
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Figure 7. Inhibition IgE immunoblot with rPor p 1. Patient serum was preincubated with rPor p 1 at 0.4 μg mL−1 (iii), 2 μg mL−1 (iv), and 10 μg mL−1,
(v) and immunoblotted against: cooked calamari extract A) patient A5, B) patient A9; cooked mussel extract C) patient A9, D) patient A5; cooked scallop
extract E) patient A9, F) patient A13; and cooked oyster extract G) patient A12, H) patient A10. No inhibitor (i) and OVA at 20 μg mL−1 (vi) were used
as negative controls. Same inhibitor as extract was used as a positive control (ii).
hemocyanin (75 kDa),[32] myosin heavy chain (>208 kDa)[33] and
amylase (60 kDa).[34] Patient IgE reactivity was also observed to
other, previously uncharacterized, proteins. Since the SRO was
most IgE reactive in this study, we further characterized po-
tential allergens of this species by excising IgE-reactive bands
for mass spectrometric identification. Tropomyosin was iden-
tified at 34, 39, 45, and 72 kDa in the heated extract, consis-
tent with degradation and aggregation on heating. Four other
proteins were identified from other bands as putative allergens
in SRO. Glyceraldehyde-3-phosphate dehydrogenase, fructose-
bisphosphate aldolase, and arginine kinase were identified in
the raw but not cooked SRO preparation, consistent with heat-
sensitive allergens as seen for Pacific oyster[15] and crustacean
species,[35,36] whereas myosin heavy chain was heat stable. Fur-
ther IgE binding studies are required using purified or recombi-
nant proteins for IUIS allergen designation.
IgE reactivity and allergen sensitization can be affected by food
processing.[37,38] We found that heating increased overall IgE re-
activity of mollusc extracts detected by ELISA as we reported
previously for crustacean species.[16,39] That cooked extracts also
caused increased basophil activation suggests that increased well
coating efficiency was not a major reason for greater reactivity
in the ELISA. Likewise, although loss of non-allergenic compo-
nents on heating could play a role, the immunoblotting results
showed cooked extracts to have a very different profile of IgE-
reactive bands rather than a similar pattern of bands at higher
intensity compared with raw extracts. Taken together, our results
are consistent with cooking-induced increased IgE reactivity of
certain mollusc proteins.
While manymolluscs are cooked before ingestion, thereby po-
tentially presenting heat-modified allergens to the patient’s im-
mune system, this is not usual for oysters. An alternative ex-
planation for the increased IgE reactivity of cooked extracts is
that cooking in the presence of endogenous or exogenous sug-
ars results in generation of advanced glycation end products due
to the Maillard reaction.[40,41] Glycated allergens are reported to
have enhanced IgE binding.[23,42] However, there are no clear pat-
terns indicating how different allergens respond to food process-
ing. Our IgE immunoblotting studies showed enhanced reactiv-
ity of bands for the cooked mussel, scallop, and oyster extracts,
but decreased reactivity for the cooked calamari extract. Differ-
ent allergen profiles for the species (as shown here) and different
Mol. Nutr. Food Res. 2018, 62, 1800148 1800148 (9 of 12) C© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Table 2. Proteins identified from IgE-reactive bands of Sydney rock oyster extracts.
Band
Molecular mass
Protein name
Species
Accession no.
Score Peptide matches % Coverage
CO1
34 kDa
Tropomyosin
Haliotis rufescens
CAA53028.1
97 2(2) 10
CO2
39 kDa
Tropomyosin
Chlamys nipponensis akazara
O02389.1
579 36(19) 25
CO3
45 kDa
Tropomyosin
Chlamys nipponensis akazara
O02389.1
100 5(2) 19
CO4
72 kDa
Tropomyosin
Chlamys nipponensis akazara
O02389.1
80 2(2) 7
CO5
89 kDa
Myosin heavy chain, striated muscle
Argopecten irradians
P24733.1
191 8(4) 2
RO1
38 kDa
Glyceraldehyde-3-phosphate dehydrogenase
Danio rerio
Q5XJ10.2
66 7(2) 5
RO2
45 kDa
Fructose-bisphosphate aldolase A
Salmo salar
NP 001133181.1
74 1(1) 3
Arginine kinase
Haliotis madaka
P51544.1
54 1(1) 5
Saccostrea glomerata 1 MDSIKKKMIA MKMEKENAQD RAEQLEQQLR DTEEQKAKIE EDLTTLQKKH SNLENEFDIV
Crassostrea gigas 1 ---------- ---------- ---------- ---------- ----S----- --------T-
Mytilus edulis 1 --A-----V- --------L- -------K-- E---A----- D-YNS----S IQT--DL-NT
Todarodes pacificus 1 --A-----L- ------V-T- K---T--S-- -L-AA-NT-- ---S-----Y -----D--NA
Argopecten irradians 1 --A-----Q- --VDR----- L---M--K-K ---TA---L- --FND----L TTT--N---S
Portunus pelagicus 1 --A-----Q- --L--DD-M- --DT----NK EANIRAE-A- -EVHN---RM QQ---DL-Q-
Saccostrea glomerata 61 NEKYQDCQAK YEEAEKKASE SEQEIQSLNR RIQLLEEDME RSEERLQTAT EKLEEASKAA
Crassostrea gigas 61 -----E--T- L-----T--- A--------- ---------- ---------- ----------
Mytilus edulis 61 QTQL--V--- --TT--QIA- H-------T- K-SM----IM K----YT--A S---------
Todarodes pacificus 61 K-NLTVANTN L-AS--RVN- C-S---G--- --------L- ------TS-Q S---D-----
Argopecten irradians 61 --QL--ANT- L-N---QITQ L-SDVAG-Q- -L------Y- ----K-NSTS ----------
Portunus pelagicus 61 Q-SLLKANTQ L--KD-AL-N A-G-VAA--- --------L- ------N--- T--A---Q--
Saccostrea glomerata 121 DESERNRKVL ENLNNASEER TDVLEKQLTE AKLIAEEADK KYDEAARKLA ITEVDLERAE
Crassostrea gigas 121 ---------- ---------- ---------- ---------- ---------- ----------
Mytilus edulis 121 ---------- ----CGND-- I-Q------- --W------- --E------- ----------
Todarodes pacificus 121 -----G---- --RSQGD--- I-L-----E- --W---D--R -F-------- ----------
Argopecten irradians 121 --------A- -GK--TN--- I-E-----DS --NV-QD--S -F-------- ----------
Portunus pelagicus 121 -----M---- --RSLSD--- M-A--N--K- -RFL-----R ----V----- MV-A------
Saccostrea glomerata 181 ARLEAAEAKV IDLEEQLSVV GNNIKTLQVQ NDQASQREDS YEETIRDLTQ RLKDAENRAT
Crassostrea gigas 181 ---------- YE-------- A--------- ---------- ---------- ----------
Mytilus edulis 181 ---------- -------T-- -A-------- ---------- ---------N ----------
Todarodes pacificus 181 ---------I VE---E-K-- ---M-S-EIS EQE------- ---------H ---E-----A
Argopecten irradians 181 T-----D--- LE---E-T-- -A-------- ---------- ---------K S---------
Portunus pelagicus 181 E-A-TG-S-I VE---E-R-- ---L-S-E-S EEK-N---EA -K-Q-KT--N K--A--A--E
Saccostrea glomerata 241 EAERTVSKLQ KEVDRLEDEL LAEKERYKAI SDELDQTFAE LAGY
Crassostrea gigas 241 ---------- ---------- ---------- ---------- ---- 96.5% (10aa diff)
Mytilus edulis 241 ---------R ---------- -T---K---- -----A---- ---- 80.6% (55aa diff)
Todarodes pacificus 241 ---------- ---------- --------S- ---------- ---- 75% (71aa diff)
Argopecten irradians 241 ----Q-T--- ---------- ---------- ---------- I--- 74.3% (73aa diff)
Portunus pelagicus 241 F---S-Q--- ---------- VN---K--ST T-----A-S- -S—v  60.2% (113aa diff)
Figure 8. Tropomyosin sequence alignment. Alignment of tropomyosin sequences with Saccostrea glomerata (Sydney rock oyster) tropomyosin, Sac
g 1 (GenBank accession number MF996471) as reference using NCBI Protein BLAST. Species include the bivalves Crassostrea gigas (Pacific oyster;
ARX70262), Mytilus edulis (blue mussel; Q25457), Argopecten irradians (bay scallop; AAX37290), the cephalopod Todarodes pacificus (Japanese flying
squid; BAE54431) and the crustacean Portunus pelagicus (blue swimmer crab; AGE44125). Sequence identity is also shown.
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endogenous sugars may explain these differing effects of heat-
ing. That increased IgE reactivity of calamari on cooking was
seen by ELISA and not immunoblotting, might also be due to
IgE-reactive protein aggregation or degradation to small peptides
such that they are not observed on the gel but remain in the whole
extract for detection by ELISA.
Clinical management of mollusc allergy includes avoidance
of the offending species. It is therefore critical to understand
the cross-reactivity between different mollusc species to avoid
accidental allergen exposure and potentially severe allergic
reactions. Allergen cross-reactivity between mollusc species
and other animals has been suggested both experimentally and
clinically.[2,43–45] In this study, the amino acid identity between
SRO tropomyosin and other knownmollusc tropomyosins could
be as low as 74%, suggesting tropomyosin may not be solely
responsible for the cross-reactivity observed.[13] Our inhibition
IgE ELISA studies showed that oyster (a bivalve) had the highest
level of overall cross-reactivity with other mollusc species. Cala-
mari (a cephalopod) and scallop (a bivalve) also demonstrated
a high level of cross-reactivity to each other and with oyster,
suggesting taxonomical relativity plays a minor role in mollusc
cross-reactivity. Overall, mussel inhibition was the lowest. These
results may reflect differences in abundance of cross-reactive
allergens or epitopes in different mollusc extracts. Our findings
suggest that oyster, scallop and calamari-sensitized patients
should be particularly vigilant in avoiding any mollusc species.
Patients with putative mollusc tropomyosin reactivity also
demonstrated IgE cross-reactivity with the major crustacean
tropomyosin Por p 1 previously identified by us.[16] rPor p 1
diminished IgE binding to tropomyosin of cooked calamari,
mussel, scallop, and oyster extracts in most subjects. The
moderate to high sequence identity between tropomyosins of
SRO and other shellfish species suggests IgE epitope similarity
as the major determinant of tropomyosin IgE cross-reactivity.
High sequence homology has previously been associated with
high affinity and shared IgE binding epitopes of allergens.[46]
Future studies should identify the precise IgE binding regions
of mollusc tropomyosins.
Taken together, our novel findings on the characterization of
allergenic proteins of mollusc species should inform develop-
ment of reliable component-resolved diagnostic assays for mol-
lusc allergy and enable accurate dietary advice.[47] Diagnostic pre-
cision will be enhanced by including the appropriate range of pu-
rified allergens from relevant species including those prepared
from raw or cooked extracts as appropriate. Coupled with promis-
ing advances in delivering hypoallergenic preparations, knowl-
edge of clinically important mollusc allergens provides crucial
platform knowledge for the development of much needed safe
and efficacious specific immunotherapy for mollusc allergy.[48,49]
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